Clinical Trials Browser

Castleman Disease × 1 year × Clear all

NCT05028621 2026-02-20

Molecular Basis of Langerhans and Non-Langerhans Cell Histiocytic Neoplasms and Castleman Disease

Phase NA Suspended

LymphoidMyeloid

Castleman Disease, Histiocytosis, Langerhans-Cell, Histiocytosis, Non-Langerhans-Cell

NCT03300830 2026-02-05

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

LymphoidSarcoma

Acquired Immunodeficiency Syndrome, Castleman Disease, Immunologic Deficiency Syndromes, Sarcoma, Kaposi

NCT03717844 2025-11-20

Registry for Adults With Plasma Cell Disorders (PCD's)

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Multiple Myeloma, POEMS Syndrome

NCT01552434 2025-10-14

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Phase 1 Active not recruiting

BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease